These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27770470)

  • 1. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
    Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
    JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
    Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
    Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET.
    Sigurdardottir HL; Kranz GS; Rami-Mark C; James GM; Vanicek T; Gryglewski G; Kautzky A; Hienert M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Rujescu D; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2016 Mar; 37(3):884-95. PubMed ID: 26678348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between brain serotonin transporter binding and impulsivity and aggression in healthy individuals.
    da Cunha-Bang S; Frokjaer VG; Mc Mahon B; Jensen PS; Svarer C; Knudsen GM
    J Psychiatr Res; 2023 Sep; 165():1-6. PubMed ID: 37441926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.
    James GM; Baldinger-Melich P; Philippe C; Kranz GS; Vanicek T; Hahn A; Gryglewski G; Hienert M; Spies M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Front Hum Neurosci; 2017; 11():48. PubMed ID: 28220069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
    Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
    Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: Implications on treatment of depression and ADHD.
    Ding YS; Naganawa M; Gallezot JD; Nabulsi N; Lin SF; Ropchan J; Weinzimmer D; McCarthy TJ; Carson RE; Huang Y; Laruelle M
    Neuroimage; 2014 Feb; 86():164-71. PubMed ID: 23933039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal serotonin transporter availability in the brains of adults with conduct disorder.
    Chang C; Gau SS; Huang WS; Shiue CY; Yeh CB
    J Formos Med Assoc; 2017 Jun; 116(6):469-475. PubMed ID: 27771175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.
    Wilson H; Giordano B; Turkheimer FE; Chaudhuri KR; Politis M
    Neuroimage Clin; 2018; 18():630-637. PubMed ID: 29845011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study.
    Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
    Mol Psychiatry; 2021 Aug; 26(8):3970-3979. PubMed ID: 31822819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia.
    Tominaga K; Tsumoto C; Ataka S; Mizuno K; Takahashi K; Yamagami H; Tanigawa T; Kawabe J; Watanabe T; Fujiwara Y; Shiomi S; Watanabe Y; Arakawa T
    Life Sci; 2015 Sep; 137():150-7. PubMed ID: 26232557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.
    Nye JA; Purselle D; Plisson C; Voll RJ; Stehouwer JS; Votaw JR; Kilts CD; Goodman MM; Nemeroff CB
    Depress Anxiety; 2013 Oct; 30(10):902-7. PubMed ID: 23526784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.